These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9048280)

  • 1. Usefulness, usability, and quality criteria for noninvasive methods in cardiovascular clinical pharmacology.
    de Mey C; Erb KA
    J Clin Pharmacol; 1997 Jan; 37(S1):11S-20S. PubMed ID: 9048280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic time intervals in clinical pharmacology.
    Li Q; Belz GG
    Eur J Clin Pharmacol; 1993; 44(5):415-21. PubMed ID: 8359176
    [No Abstract]   [Full Text] [Related]  

  • 3. Part 6: advanced cardiovascular life support. Section 6: pharmacology II: agents to optimize cardiac output and blood pressure. European Resuscitation Council.
    European Resuscitation Council.
    Resuscitation; 2000 Aug; 46(1-3):155-62. PubMed ID: 10978796
    [No Abstract]   [Full Text] [Related]  

  • 4. Systolic time intervals--a new technique in clinical pharmacology.
    Warrington S
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):93-8. PubMed ID: 3990448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The problems of the experimental and clinical pharmacology of venotropic drugs].
    Shashkov VS; Modin AIu; Shashkov AV
    Eksp Klin Farmakol; 1998; 61(3):3-9. PubMed ID: 9690066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic surrogate end-points in phase I studies?
    De Mey C
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):175-9. PubMed ID: 9112140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual Congress of the European Society of Cardiology: Aug 30-Sept 3 2014; Barcelona, Spain.
    Prakash A
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):69-72. PubMed ID: 25617012
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.
    Bøtker HE; Hausenloy D; Andreadou I; Antonucci S; Boengler K; Davidson SM; Deshwal S; Devaux Y; Di Lisa F; Di Sante M; Efentakis P; Femminò S; García-Dorado D; Giricz Z; Ibanez B; Iliodromitis E; Kaludercic N; Kleinbongard P; Neuhäuser M; Ovize M; Pagliaro P; Rahbek-Schmidt M; Ruiz-Meana M; Schlüter KD; Schulz R; Skyschally A; Wilder C; Yellon DM; Ferdinandy P; Heusch G
    Basic Res Cardiol; 2018 Aug; 113(5):39. PubMed ID: 30120595
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs used in heart disease. 1. Pharmacology--1.
    Landowski R; Shulman R; Davies R
    Nurs Times; 2002 Apr 30-May 6; 98(18):43-6. PubMed ID: 12035447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular pharmacology].
    Ravens U; Erdmann E
    Dtsch Med Wochenschr; 2004 Apr; 129(15):799. PubMed ID: 15054684
    [No Abstract]   [Full Text] [Related]  

  • 11. Test of the usefulness of a paradigm to identify potential cardiovascular liabilities of four test articles with varying pharmacological properties in anesthetized guinea pigs.
    Kijtawornrat A; Ueyama Y; del Rio C; Sawangkoon S; Buranakarl C; Chaiyabutr N; Hamlin RL
    Toxicol Sci; 2014 Feb; 137(2):458-68. PubMed ID: 24189130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Pharmacology: An Update and Anesthesia Considerations.
    Asgarian C; Liu H; Kaye AD
    Anesthesiol Clin; 2017 Jun; 35(2):273-284. PubMed ID: 28526148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology quality assurance for HIV and related infectious diseases research.
    DiFrancesco R; Tooley K; Rosenkranz SL; Siminski S; Taylor CR; Pande P; Morse GD
    Clin Pharmacol Ther; 2013 Jun; 93(6):479-82. PubMed ID: 23588323
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacology of the drugs prescribed for chronic venous diseases].
    Talibov OB
    Khirurgiia (Mosk); 2019; (2):106-109. PubMed ID: 30855600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of optimal design methodologies in clinical pharmacology experiments.
    Ogungbenro K; Dokoumetzidis A; Aarons L
    Pharm Stat; 2009; 8(3):239-52. PubMed ID: 19009585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards Drugs and Devices Synergy. A new session track at EuroPCR: PCR clinical algorithms.
    Steg PG; Wijns W
    EuroIntervention; 2018 Apr; 13(17):1991-1992. PubMed ID: 29569561
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.
    Cavallari LH; Weitzel K
    Future Cardiol; 2015 May; 11(3):281-6. PubMed ID: 26021633
    [No Abstract]   [Full Text] [Related]  

  • 18. Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies.
    Vaduganathan M; Butler J; Pitt B; Gheorghiade M
    Circ Heart Fail; 2015 Jul; 8(4):826-31. PubMed ID: 26199309
    [No Abstract]   [Full Text] [Related]  

  • 19. Methods in clinical pharmacology.
    Ritter JM
    Br J Clin Pharmacol; 2009 Jul; 68(1):1-3. PubMed ID: 19659997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems of long-term therapy and therapeutic damage considering the clinical aspects. Cardiology].
    Lüderitz B
    Verh Dtsch Ges Inn Med; 1991; 97():34-43. PubMed ID: 1808909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.